Pain

Triple-I: Dog-Related Injury Claim Payouts Hit $1.12 Billion in 2023

Retrieved on: 
Monday, April 8, 2024
Veterinary, Insurance, Pets, General Health, Health, Family, Professional Services, Consumer, Eating, Socialization, Personality, American Veterinary Medical Association, Walking, Biting, Education, Knowledge, Veterinarian, Dog, Safety, AVMA, Injury, Pain, Pet, Animal, State, Hunting

On a positive note, the average cost per claim decreased from $64,555 in 2022 to $58,545 in 2023.

Key Points: 
  • On a positive note, the average cost per claim decreased from $64,555 in 2022 to $58,545 in 2023.
  • “Education and training for owners and pets is key to keep everyone safe and healthy,” said Ruiz.
  • “It is important to recognize that any dog, including ones that are in the home, can bite or cause injury.
  • As we mark National Dog Bite Prevention Week, let's commit to increasing our understanding of the issue and taking proactive steps towards prevention.

Align Technology Launches Integrated Consumer Campaign and #Invisisforkids to Drive Awareness of How the Invisalign® Palatal Expander System Is a Better Option for Expanding a Child’s Narrow Palate to Make Room for Adult Teeth

Retrieved on: 
Monday, April 8, 2024
Health, Parenting, Medical Devices, Children, Family, Health Technology, Consumer, Dental, Align Technology, Patient, Social media, Child, Anxiety, Trial of the century, Pain, Multimedia, Oral hygiene, FDA, Parent, IPE

The Invisalign Palatal Expander System is the only FDA-cleared, removable palatal expander that’s just as effective as traditional fixed expanders.

Key Points: 
  • The Invisalign Palatal Expander System is the only FDA-cleared, removable palatal expander that’s just as effective as traditional fixed expanders.
  • 3 With no metal or wires in the way, your child can easily pop out the Invisalign Palatal Expander to brush and floss as usual.
  • Based on data from a multi-site US IDE clinical study (n=29 subjects, ages 7-10 years) of expansion treatment with Invisalign® Palatal Expanders.
  • Data on file at Align Technology, as of September 5, 2023.

Ferring Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603 (condoliase), in Lumbar Disc Herniation at ASIPP 2024

Retrieved on: 
Monday, April 8, 2024
Biotechnology, Men, Health, Consumer, Other Health, Pharmaceutical, Surgery, Other Science, Research, Medical Devices, Science, Women, Seniors, Clinical Trials, Week, Sciatica, LDH, Incidence, Ferring Pharmaceuticals, Patient, Spinal disc herniation, Șaeș, University, ESI, Quality of life, Manager, University of Illinois Urbana-Champaign, Society, Back pain, LSM, Pain, SAE

"Based on these findings, SI-6603 could provide another option where a single injection to the lumbar disc could offer patients significant relief from the unrelenting pain often associated with lumbar disc herniation."

Key Points: 
  • "Based on these findings, SI-6603 could provide another option where a single injection to the lumbar disc could offer patients significant relief from the unrelenting pain often associated with lumbar disc herniation."
  • An analysis assessing current treatment patterns and gaps in clinical management of patients with newly diagnosed LDH was also presented.
  • The analysis reviewed medical claims data of more than a million U.S. patients over a four-year period.
  • Among patients who received more than one ESI, one in five (22.4%) underwent surgery with 14.2% of those patients receiving repeated surgeries.

Pair of Digital Health Research Papers Coauthored by Analysis Group Demonstrate Promises of Wearables to Generate Reliable Site-Less Patient-Reported Outcomes in Rheumatoid Arthritis

Retrieved on: 
Tuesday, April 9, 2024
Yee, Aiden, Principal, Observational study, Scientific Reports, Apple, Rheumatoid arthritis, Digital, University, GSK, Bias, Patient, PRO, Research, Nature, Hamy, Analysis Group, Apple Watch, Creagh, Pain, Machine learning, Fatigue

This technology enables clinicians to develop more sensitive and patient-centric endpoints in RA clinical trials and real-world studies.

Key Points: 
  • This technology enables clinicians to develop more sensitive and patient-centric endpoints in RA clinical trials and real-world studies.
  • "Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis," published in February by Nature's npj Digital Medicine (Creagh, A.P., et al.
  • "Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis."
  • "Patient-centric assessment of rheumatoid arthritis using a smartwatch and bespoke mobile app in a clinical setting."

Global Elbow Replacement Market to surpass $200.4 million by 2031, at a CAGR of 4.2%, says Coherent Market Insights

Retrieved on: 
Monday, April 8, 2024
Longevity, Rheumatoid arthritis, Prevalence, Partnership, Patient, AAOS, Elbow, Polyethylene, American Academy, Acquisition, Motion, Quality of life, Injury, Integra, Shoulder, Metal, Partial, Key, Pain, Osteoarthritis, USD, Collection, Plumbing

Elbow replacement surgery is a medical procedure that involves replacing a damaged or diseased elbow joint with an artificial implant.

Key Points: 
  • Elbow replacement surgery is a medical procedure that involves replacing a damaged or diseased elbow joint with an artificial implant.
  • As per the market research report, the elbow replacement market was valued at USD 144.2 million in 2023, with a projected CAGR of 4.2% during the forecast period 2024-2031.
  • Buy this Complete Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/6663
    In terms of type, the elbow replacement market is segmented into partial elbow replacement and total elbow replacement.
  • Partial elbow replacement is expected to dominate the market, owing to its less invasive nature and shorter recovery time compared to total elbow replacement.

Global Elbow Replacement Market to surpass $200.4 million by 2031, at a CAGR of 4.2%, says Coherent Market Insights

Retrieved on: 
Monday, April 8, 2024
Longevity, Rheumatoid arthritis, Prevalence, Partnership, Patient, AAOS, Elbow, Polyethylene, American Academy, Acquisition, Motion, Quality of life, Injury, Integra, Shoulder, Metal, Partial, Key, Pain, Osteoarthritis, USD, Collection, Plumbing

Elbow replacement surgery is a medical procedure that involves replacing a damaged or diseased elbow joint with an artificial implant.

Key Points: 
  • Elbow replacement surgery is a medical procedure that involves replacing a damaged or diseased elbow joint with an artificial implant.
  • As per the market research report, the elbow replacement market was valued at USD 144.2 million in 2023, with a projected CAGR of 4.2% during the forecast period 2024-2031.
  • Buy this Complete Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/6663
    In terms of type, the elbow replacement market is segmented into partial elbow replacement and total elbow replacement.
  • Partial elbow replacement is expected to dominate the market, owing to its less invasive nature and shorter recovery time compared to total elbow replacement.

Outreach - Spiritual Writers and Readers Wanted to Balance Ministration - Apply Below

Retrieved on: 
Monday, April 8, 2024
Universe, Universal mind, Speech, Spirituality, Communication, Metaphysics, Internet, Perception, Sale, Data format, Life, Irritation, Universal, Pain, Outreach, Ministry, Judaism, Movement, Nursing

LAS VEGAS, April 8, 2024 /PRNewswire-PRWeb/ -- How does one broadcast their message? There is a speech before the gathering, the written word, signs, displays, the Internet, websites, and email.

Key Points: 
  • Solicited Spiritual writers may offer their independent and Self-published work at their desired rate.
  • It aids the seeker in placing Universal thought before them to investigate other spiritual domains.
  • Inviting others who write about (and perform) Metaphysical practices to participate in this venture opens the willing reader's mind to latent possibilities.
  • With the advent of my spiritual awakening while writing Outreach Mojave, the remaining three novel outlines remain in the filing cabinet."

Battle Born Brain and Spine Introduces Amplify DualPortal Endoscopic Surgery - Revolutionizing Spine Care in Northern Nevada

Retrieved on: 
Friday, April 5, 2024
Patient, Spine, Tissue, Trauma, Pain

CARSON CITY, Nev., April 5, 2024 /PRNewswire-PRWeb/ -- Battle Born Brain and Spine, a leading neurosurgical practice in Northern Nevada, proudly announces the launch of Amplify DualPortal Endoscopic Surgery, the first and only official endoscopic spine surgical practice in the region. This innovative approach to spine surgery is set to revolutionize the way patients receive care for spinal conditions, offering ultra minimally invasive solutions with improved outcomes.

Key Points: 
  • Dr. Sina Rajamand, at Battle Born Brain and Spine in Carson City Nevada, is a leading expert in Endoscopic Spine Surgery, known for his conservative approach and exceptional patient outcomes.
  • CARSON CITY, Nev., April 5, 2024 /PRNewswire-PRWeb/ -- Battle Born Brain and Spine, a leading neurosurgical practice in Northern Nevada , proudly announces the launch of Amplify DualPortal Endoscopic Surgery , the first and only official endoscopic spine surgical practice in the region.
  • The introduction of Amplify Dualportal Endoscopic Surgery further solidifies the practice's reputation as a leader in innovative spine care in the region.
  • For more information about Amplify DualPortal Endoscopic Surgery at Battle Born Brain and Spine, please visit https://www.battlebornbrainandspine.com/ or contact (775) 445-6622.

Pryon Selected for the 2024 CB Insights AI 100 List

Retrieved on: 
Friday, April 5, 2024
Intelligence, RAG, Lightning, Pain, CB Insights, Research, Face, Netflix, AI, Online shopping

RALEIGH, N.C., April 5, 2024 /PRNewswire/ -- CB Insights today named Pryon, a leader in Retrieval Augmented Generation (RAG) solutions, to its eighth-annual AI 100, showcasing the 100 most promising private AI companies of 2024. This year's winners are recognized for tackling some of the hardest challenges in scaling AI across industries, and Pryon, having pioneered best-in-class RAG solutions, earned its spot on the list for its capabilities to increase productivity through AI applications.

Key Points: 
  • RALEIGH, N.C., April 5, 2024 /PRNewswire/ -- CB Insights today named Pryon , a leader in Retrieval Augmented Generation (RAG) solutions, to its eighth-annual AI 100 , showcasing the 100 most promising private AI companies of 2024.
  • "AI is taking off at lightning speed, and it's not just big tech companies at the forefront of it," said Deepashri Varadharajan, director of AI research at CB Insights.
  • "Our AI 100 winners – many of them early-stage startups, some with very small teams – are pushing the boundaries of AI in everything from game development and battery design to agentic AI systems."
  • For more information about Pryon, please visit https://pryon.com
    For the full list of the most promising artificial intelligence startups of 2024, please visit https://www.cbinsights.com

Orphan designation: Nirogacestat Treatment of soft tissue sarcoma, 17/10/2019 Positive

Retrieved on: 
Tuesday, April 9, 2024
Eurostat, Diagnosis, Civil service commission, Plantar fibromatosis, Radiation, Gene, Growth, Sarcoma, Blood, Disease, Patient, Committee, Knowledge, Tissue, Regulation, Cancer, EMA, IRIS, Radiation therapy, European, Therapy, COMP, Aggressive fibromatosis, Safety, European Commission, GS, Pain, Marketing, Swelling, Medicine, Pharmaceutical industry

Orphan designation: Nirogacestat Treatment of soft tissue sarcoma, 17/10/2019 Positive

Key Points: 


Orphan designation: Nirogacestat Treatment of soft tissue sarcoma, 17/10/2019 Positive